电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

Recombinant TNFSF11 (Denosumab Biosimilar) 抗体

This Human 单克隆 anti-TNFSF11 (Denosumab Biosimilar) antibody specifically detects TNFSF11 (Denosumab Biosimilar) in FACS, BLI, ELISA, Func 和 SPR. The antibody is reactive with 人 samples.
产品编号 ABIN7675811
发货至: 中国
Contact our Customer Service for availability and price in your country. Contact Info

Our Local Distributor

中国
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
4A Biotech Co.,Ltd.
Tel +86 (0512) 65829739 传真 +86 (010) 6788 5057

Quick Overview for Recombinant TNFSF11 (Denosumab Biosimilar) 抗体 (ABIN7675811)

抗原

TNFSF11 (Denosumab Biosimilar)

抗体类型

Recombinant Antibody

适用

宿主

  • 2
  • 1
  • 1
Human

克隆类型

  • 4
单克隆

标记

  • 3
  • 1
This TNFSF11 (Denosumab Biosimilar) antibody is un-conjugated

应用范围

Flow Cytometry (FACS), Bio-Layer Interferometry (BLI), ELISA, Functional Studies (Func), Surface Plasmon Resonance (SPR)
  • Expression System

    CHO Cells

    原理

    Anti-TNFSF11 / RANKL / CD254 Reference Antibody (denosumab)

    序列

    EVQLLESGGG LVQPGGSLRL SCAASGFTFS SYAMSWVRQA PGKGLEWVSG ITGSGGSTYY ADSVKGRFTI SRDNSKNTLY LQMNSLRAED TAVYYCAKDP GTTVIMSWFD PWGQGTLVTV SSASTKGPSV FPLAPCSRST SESTAALGCL VKDYFPEPVT VSWNSGALTS GVHTFPAVLQ SSGLYSLSSV VTVPSSNFGT QTYTCNVDHK PSNTKVDKTV ERKCCVECPP CPAPPVAGPS VFLFPPKPKD TLMISRTPEV TCVVVDVSHE DPEVQFNWYV DGVEVHNAKT KPREEQFNST FRVVSVLTVV HQDWLNGKEY KCKVSNKGLP APIEKTISKT KGQPREPQVY TLPPSREEMT KNQVSLTCLV KGFYPSDIAV EWESNGQPEN NYKTTPPMLD SDGSFFLYSK LTVDKSRWQQ GNVFSCSVMH EALHNHYTQK SLSLSPGK,EIVLTQSPGT LSLSPGERAT LSCRASQSVR GRYLAWYQQK PGQAPRLLIY GASSRATGIP DRFSGSGSGT DFTLTISRLE PEDFAVFYCQ QYGSSPRTFG QGTKVEIKRT VAAPSVFIFP PSDEQLKSGT ASVVCLLNNF YPREAKVQWK VDNALQSGNS QESVTEQDSK DSTYSLSSTL TLSKADYEKH KVYACEVTHQ GLSSPVTKSF NRGEC

    产品特性

    Anti-TNFSF11 / RANKL / CD254 Reference Antibody (denosumab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.

    纯度

    >95 %

    亚型

    IgG1
  • 应用备注

    Optimal working dilution should be determined by the investigator.

    说明

    Therapeutic Agents by Target and Mechanism: RANKL inhibitors

    限制

    仅限研究用
  • 状态

    Lyophilized

    浓度

    1 mg/mL

    缓冲液

    25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

    储存条件

    4 °C,-80 °C

    储存方法

    +4°C,-80°C
  • 抗原

    TNFSF11 (Denosumab Biosimilar)

    物质类

    Biosimilar

    分子量

    145.5 kDa

    UniProt

    O14788
You are here: